Tag: EyePoint Pharmaceuticals

Industry News
EyePoint Pharmaceuticals and OcuMension Therapeutics Announced the Approval of New Drug Application for YUTIQ by China’s NMPA for the Treating of Chronic Non-Infectious Uveitis Affecting the Posterior Section of the Eye

EyePoint Pharmaceuticals and OcuMension Therapeutics Announced...

On June 21, 2022,- EyePoint Pharmaceuticals, Inc. a pharmaceutical company devoted...